LEGN

Legend Biotech Corporation NASDAQ

Healthcare ·Biotechnology ·US · legendbiotech.com

$26.50

Mkt Cap $4.9B

52w Low $16.24 35.3% of range 52w High $45.30

50d MA $19.71 200d MA $27.05

P/E (TTM) -14.7x

EV/EBITDA -32.6x

P/B 4.3x

Debt/Equity 0.4x

ROE —

P/FCF -23.8x

RSI (14) —

ATR (14) —

Beta 0.08

50d MA $19.71

200d MA $27.05

Avg Volume 2.0M

About

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatm…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Mar 10, 2026	AMC	-0.17	-0.08	+52.9%	19.56	+0.5%	+3.6%	-2.6%	-4.1%	-2.4%	-5.2%	-7.0%	—
Nov 12, 2025	AMC	-0.13	-0.11	+15.4%	31.18	-1.3%	-0.5%	-2.9%	-4.7%	-5.6%	-10.2%	-28.4%	—
Aug 11, 2025	AMC	-0.22	-0.34	-54.5%	36.24	-0.3%	+2.1%	+1.9%	+4.1%	+3.5%	+3.3%	-7.6%	—
May 13, 2025	AMC	-0.40	-0.07	+82.5%	31.08	+0.7%	-10.6%	-10.9%	-10.6%	-6.3%	-3.2%	+22.0%	—
Mar 11, 2025	AMC	-0.39	-0.15	+61.5%	37.19	+1.9%	+2.8%	+2.3%	+0.0%	+2.0%	+1.9%	-15.9%	—
Aug 9, 2024	AMC	-0.54	-0.05	+90.7%	55.90	+2.4%	+0.6%	+2.1%	-2.2%	-0.3%	+1.8%	-9.9%	—
May 13, 2024	AMC	-0.29	-0.16	+44.8%	42.97	+0.7%	+3.3%	+6.5%	+7.9%	+5.1%	+5.7%	+6.5%	—
Mar 11, 2024	AMC	-0.70	-0.40	+42.9%	65.19	-0.6%	-0.1%	+4.3%	+1.4%	-1.8%	-0.8%	-14.9%	—
Nov 20, 2023	AMC	-0.56	-0.17	+69.6%	60.50	+0.0%	-5.4%	-0.6%	-0.0%	+1.8%	-0.8%	-0.8%	—
Aug 15, 2023	AMC	-0.69	-0.27	+60.9%	66.95	+0.4%	+1.0%	-0.1%	-0.9%	+1.7%	+4.0%	-2.7%	—
May 18, 2023	AMC	-0.56	-0.40	+28.6%	68.94	+4.6%	+1.1%	+0.0%	-3.5%	-4.2%	-8.2%	+4.8%	—
Mar 30, 2023	AMC	-0.44	-0.85	-94.2%	48.00	-2.1%	+0.5%	-2.0%	-3.6%	+0.4%	+6.8%	+40.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$25.07	$25.08	+0.0%	+0.6%	+3.4%	-4.3%	-4.7%	-5.7%
Apr 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$18.69	$18.92	+1.2%	+9.8%	+12.8%	+13.3%	+34.1%	+34.9%
Mar 11	Morgan Stanley	Maintains	Overweight → Overweight	—	$19.56	$19.66	+0.5%	+3.6%	-2.6%	-4.1%	-2.4%	-5.2%
Mar 11	RBC Capital	Maintains	Outperform → Outperform	—	$19.56	$19.66	+0.5%	+3.6%	-2.6%	-4.1%	-2.4%	-5.2%
Feb 4	Barclays	Maintains	Overweight → Overweight	—	$16.66	$16.61	-0.3%	-0.1%	+0.2%	+2.6%	+3.2%	+7.5%
Jan 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$20.76	$20.08	-3.3%	-6.8%	-8.4%	-8.7%	-12.0%	-14.0%
Jan 22	TD Cowen	Downgrade	Buy → Hold	—	$20.76	$20.08	-3.3%	-6.8%	-8.4%	-8.7%	-12.0%	-14.0%
Jan 20	RBC Capital	Maintains	Outperform → Outperform	—	$22.14	$21.70	-2.0%	+5.8%	-6.2%	-12.6%	-14.1%	-14.4%
Dec 17	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$21.65	$21.67	+0.1%	-1.1%	-1.7%	+1.2%	+4.8%	+5.5%
Dec 12	Morgan Stanley	Maintains	Overweight → Overweight	—	$23.01	$22.91	-0.4%	-3.0%	-4.3%	-5.9%	-6.9%	-7.5%
Dec 8	UBS	Maintains	Buy → Buy	—	$28.13	$27.84	-1.0%	-7.1%	-15.1%	-17.0%	-18.2%	-20.7%
Nov 13	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$31.18	$30.77	-1.3%	-0.5%	-2.9%	-4.7%	-5.6%	-10.2%
Nov 13	Barclays	Maintains	Overweight → Overweight	—	$31.18	$30.77	-1.3%	-0.5%	-2.9%	-4.7%	-5.6%	-10.2%
Nov 13	RBC Capital	Maintains	Outperform → Outperform	—	$31.18	$30.77	-1.3%	-0.5%	-2.9%	-4.7%	-5.6%	-10.2%
Oct 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$32.36	$31.80	-1.7%	-1.2%	+1.7%	+1.5%	-0.8%	-2.1%
Oct 9	JP Morgan	Maintains	Overweight → Overweight	—	$32.21	$32.05	-0.5%	+0.0%	-1.6%	+2.0%	+3.2%	+4.7%
Aug 25	JP Morgan	Maintains	Overweight → Overweight	—	$35.56	$35.72	+0.4%	-2.7%	-1.3%	-2.4%	-3.3%	-2.3%
Aug 12	RBC Capital	Maintains	Outperform → Outperform	—	$36.24	$36.13	-0.3%	+2.1%	+1.9%	+4.1%	+3.5%	+3.3%
Aug 12	Morgan Stanley	Maintains	Overweight → Overweight	—	$36.24	$36.13	-0.3%	+2.1%	+1.9%	+4.1%	+3.5%	+3.3%
Jul 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$39.75	$41.20	+3.6%	+6.0%	+4.6%	+6.2%	+10.7%	+11.5%
Jul 10	Morgan Stanley	Maintains	Overweight → Overweight	—	$39.46	$39.53	+0.2%	+0.6%	-1.3%	-0.1%	+0.3%	+0.7%
Jul 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$35.87	$35.78	-0.3%	+4.5%	+10.0%	+10.7%	+8.6%	+10.0%
Jul 2	UBS	Maintains	Buy → Buy	—	$36.29	$36.30	+0.0%	-1.0%	-1.8%	-1.2%	+3.3%	+8.7%
May 14	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$31.08	$31.30	+0.7%	-10.6%	-10.9%	-10.6%	-6.3%	-3.2%
May 14	Truist	Maintains	Buy → Buy	—	$31.08	$31.30	+0.7%	-10.6%	-10.9%	-10.6%	-6.3%	-3.2%
Apr 22	RBC Capital	Maintains	Outperform → Outperform	—	$32.24	$32.99	+2.3%	+6.9%	+6.4%	+6.2%	+6.3%	+7.6%
Apr 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$33.74	$33.39	-1.0%	-0.8%	-2.8%	-4.4%	+2.2%	+1.7%
Apr 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$30.25	$31.44	+3.9%	+1.7%	+6.0%	+3.4%	+5.8%	+6.1%
Mar 17	Morgan Stanley	Maintains	Overweight → Overweight	—	$37.20	$37.41	+0.6%	+2.0%	+1.8%	+2.4%	+1.4%	-0.7%
Mar 12	Guggenheim	Maintains	Neutral → Neutral	—	$37.19	$37.91	+1.9%	+2.8%	+2.3%	+0.0%	+2.0%	+1.9%
Mar 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$37.19	$37.91	+1.9%	+2.8%	+2.3%	+0.0%	+2.0%	+1.9%
Jan 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$37.44	$37.42	-0.1%	+0.7%	-1.4%	-2.1%	-3.8%	-3.6%
Jan 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$34.67	$36.75	+6.0%	+8.0%	+8.7%	+6.5%	+5.7%	+3.9%
Jan 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$32.66	$33.41	+2.3%	+6.2%	+14.6%	+15.4%	+13.0%	+12.2%
Dec 30	Piper Sandler	Maintains	Overweight → Overweight	—	$32.49	$32.42	-0.2%	+0.9%	+0.2%	+6.9%	+10.1%	+6.9%
Dec 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$41.63	$41.50	-0.3%	-9.0%	-13.9%	-14.7%	-15.6%	-20.7%
Dec 9	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$41.54	$42.68	+2.7%	+0.2%	-8.8%	-13.7%	-14.6%	-15.5%
Dec 9	RBC Capital	Maintains	Outperform → Outperform	—	$41.54	$42.68	+2.7%	+0.2%	-8.8%	-13.7%	-14.6%	-15.5%
Nov 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$40.18	$40.50	+0.8%	-2.1%	-0.7%	-5.0%	-6.9%	-4.4%
Oct 29	RBC Capital	Maintains	Outperform → Outperform	—	$45.30	$45.35	+0.1%	+0.4%	-2.3%	-0.6%	-2.1%	-3.7%
Oct 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$44.91	$45.00	+0.2%	-2.0%	-4.1%	-4.5%	-3.3%	+0.3%
Oct 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$47.79	$48.92	+2.4%	+2.7%	+3.7%	+0.6%	+2.2%	+5.2%
Sep 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$49.27	$50.93	+3.4%	-1.1%	-3.6%	-1.2%	-3.0%	-0.4%
Sep 27	RBC Capital	Maintains	Outperform → Outperform	—	$46.85	$47.32	+1.0%	+5.2%	+4.0%	+1.3%	+3.9%	+2.0%
Aug 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$57.02	$57.40	+0.7%	-0.6%	-0.5%	+0.9%	+0.5%	+0.6%
Aug 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$55.90	$57.24	+2.4%	+0.6%	+2.1%	-2.2%	-0.3%	+1.8%
Aug 12	RBC Capital	Maintains	Outperform → Outperform	—	$55.90	$57.24	+2.4%	+0.6%	+2.1%	-2.2%	-0.3%	+1.8%
Aug 12	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$55.90	$57.24	+2.4%	+0.6%	+2.1%	-2.2%	-0.3%	+1.8%
Jul 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$55.00	$54.97	-0.1%	+5.9%	+6.8%	+7.1%	+8.9%	+8.5%
Jul 18	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$55.00	$54.97	-0.1%	+5.9%	+6.8%	+7.1%	+8.9%	+8.5%

Data updated apr 26, 2026 11:19am · Source: massive.com